"In preclinical studies, we see that the tumor — melanoma — simply dissolves, disappears, and not only the tumor itself, but even metastasis disappears. I do not rule out that we will have patients at stage 4," Gintsburg said.
He noted that at present it was planned to begin testing the effect of the drug on a number of other types of oncological diseases — lung, kidney, and pancreatic cancer. Oncology institutes are planned to be involved in this work, Gintsburg explained.
Earlier, Gintsburg told Sputnik that the cancer vaccine would be personalized, that is, it will be made for each patient individually, artificial intelligence will help in its development, which will analyze the parameters of the tumor and issue a "blueprint" of the future drug, and specialists will make a vaccine based on it within a week.